515 related articles for article (PubMed ID: 15072126)
1. Increased incidence of cytoplasmic ANCA (cANCA) and other autoantibodies in leprosy patients from western India.
Pradhan V; Badakere SS; Shankar Kumar U
Lepr Rev; 2004 Mar; 75(1):50-6. PubMed ID: 15072126
[TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil cytoplasmic antibodies (ANCA) in malaria.
Pradhan V; Badakere SS; Shankarkumar U; Iyer YS; Ghosh K; Karnad D
Indian J Malariol; 2002; 39(3-4):51-9. PubMed ID: 14686112
[TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
Pradhan VD; Badakere SS; Bichile LS; Almeida AF
J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy.
Freire BF; Ferraz AA; Nakayama E; Ura S; Queluz TT
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):475-82. PubMed ID: 10347568
[TBL] [Abstract][Full Text] [Related]
5. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis.
Ardiles LG; Valderrama G; Moya P; Mezzano SA
Clin Nephrol; 1997 Jan; 47(1):1-5. PubMed ID: 9021233
[TBL] [Abstract][Full Text] [Related]
6. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
Mathew JM; Muthukkaruppan V
Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
8. Absence of antineutrophil cytoplasmic antibodies in giant cell arteritis.
Baranger TA; Audrain MA; Castagne A; Barrier JH; Esnault VL
J Rheumatol; 1994 May; 21(5):871-3. PubMed ID: 8064728
[TBL] [Abstract][Full Text] [Related]
9. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
10. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
[TBL] [Abstract][Full Text] [Related]
11. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
Rada EM; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
[No Abstract] [Full Text] [Related]
12. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
Prasad CV; Kodliwadmath MV; Kodliwadmath GB
Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic characteristics of leprosy reactions.
Scollard DM; Smith T; Bhoopat L; Theetranont C; Rangdaeng S; Morens DM
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):559-67. PubMed ID: 7868954
[TBL] [Abstract][Full Text] [Related]
14. Is PGL-1 also present in Leishmania donovani promastigotes?
Gupta PN; Pal NK
Indian J Lepr; 1998; 70(2):161-4. PubMed ID: 9724851
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
16. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
[TBL] [Abstract][Full Text] [Related]
17. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
Chen M; Zhao MH; Zhang YK; Wang HY
Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of the presence of autoantibodies in patients with toxocariasis].
Kaya S; Demirci M; Sesli Cetin E; Cicioğlu Aridoğan B; Sahin M; Taş T; Korkmaz M
Mikrobiyol Bul; 2009 Oct; 43(4):661-6. PubMed ID: 20084921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
